Item 9 Labs, headquartered in Southern Arizona, was ranked one of the fastest growing Arizona marijuana concentrate brands according to industry data by BDS Analytics. The latest data report shows that Item 9 Labs increased its marijuana concentrate sales by 234% in Q4 compared to Q1 of calendar year 2018.
“Our sales last year surpassed our pre-expansion goals and concentrates played a big part in that growth. Concentrates appeal to patients because they offer discreetness, portability, and consistency when dosing,” stated Item 9 Labs CEO Sara Gullickson. “In 2019, we plan to diversify our product lines further and develop other comfortable health solutions for the modern cannabis consumer.”
Concentrates are the fastest growing segment of the marijuana industry according to BDS Analytics, and retail sales are projected to hit $8 billion by 2022.
Item 9 Labs is currently adding a commercial kitchen for infusion processes to its Arizona cultivation and processing facility and increasing its blueprint by 10,000 square-feet. They are also expanding their proprietary THC- and CBD-derived delivery systems, including an intra-nasal device and Apollo Vape Pen and Pod System.
Item 9 Labs owns and operates 50 acres in Southern Arizona, making it one of the largest properties in the country zoned to grow and cultivate medical marijuana. The company will be operating as licensed dispensaries, cultivation, and manufacturing facilities in a projected 10 states by the end of 2019.
Contact your local dispensary to find Item 9 Labs’ products.